AI Clinical Documentation Adoption Surges, but ROI Hinges on Governance
Largest Health Systems AI 2025 comprehensive survey to date highlights adoption momentum and governance gap in U.S. hospitals CHICAGO, IL...
Month: August 2025
Could DEA Be Next? EPA Firings Spark Questions About DEA’s Accountability in MMJ’s Marijuana Licensing Delays
After the EPA dismissed employees who publicly criticized its leadership, attention is turning to the Drug Enforcement Administration's Diversion Control...
Trimology Reviews: The Independent Expert-Backed Weight Loss Supplement That Works for Women Over 35
Why Weight Loss Feels Impossible After 35 NEW YORK CITY, NY / ACCESS Newswire / August 31, 2025 / For...
Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ESC 2025
-- Data Further Advance Understanding of VASCEPA®/VAZKEPA® Potential Mechanisms of Action --DUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 31, 2025 (GLOBE...
Novo Nordisk’s Wegovy® cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular disease
Compared with tirzepatide, Wegovy® (semaglutide 2.4 mg) showed a significant 57% greater reduction in the risk of heart attack, stroke...
KFSHRC Strengthens Its Position as a Fast-Growing Destination for International Patients
KFSHRC Strengthens Its Position as a Fast-Growing Destination for International Patients KFSHRC recorded a 47% surge in international patients in...
Novartis Leqvio® shows statistically significant and clinically meaningful early LDL-C goal achievement with less muscle pain
V-DIFFERENCE is first study to show that Leqvio prioritized after statins helps more patients achieve guideline low-density lipoprotein cholesterol (LDL-C)...
Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for people with uncontrolled hypertension
Phase III trial informed by comprehensive KARDIA data set generated through three Phase II studies: KARDIA-1, KARDIA-2 and KARDIA-3In the...
Near infrared Imaging Market worth US$2.07 billion by 2030 with 10.6% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Aug. 30, 2025 /PRNewswire/ -- The global Near infrared Imaging Market, valued at US$9.69 billion in 2023, stood...
Memory Lift Reviews: Does This Supplement Improve Brain Health? Everything You Need To Know Before Buying
MIAMI, FL / ACCESS Newswire / August 30, 2025 / In today's fast-paced world, maintaining mental sharpness, focus, and memory...
Nutriessential Celebrates 20 Years of Excellence in Premium, GMP-Certified Supplements – Expands Global Reach
MIAMI BEACH, FLORIDA / ACCESS Newswire / August 30, 2025 / Nutriessential, a U.S.-based professional-grade dietary supplement provider, proudly announces...
New REDUCE-IT® Analyses Presented at ESC 2025 Include Data Showing VASCEPA®/VAZKEPA® (Icosapent Ethyl) Therapy Resulted in 9% Fewer Total Hospitalizations & Reduces Cardiovascular Disease Risk in Certain High-Risk Patient Subgroups
-- 2025 ESC/EAS Dyslipidemia Guideline Focused Update Reaffirms High Dose Icosapent Ethyl as Class IIA Recommended Therapy in High-Risk or...
Acoramidis Demonstrates Statistically Significant Reduction in Cardiovascular Mortality (CVM) through Month 42 of the ATTRibute-CM Open Label Extension
- Acoramidis demonstrated a significant reduction in risk of CVM through 42 months post-randomization, with a 44% hazard reduction, setting...
Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine
Positive Trial Demonstrates Superiority of Aficamten to Standard-of-Care Beta-Blocker Metoprolol Primary Endpoint Result Consistent Across All Prespecified Subgroups Company to...
Aja Health and Wellness Inc. Announces Agreement for the Purchase of Assets of Canadian Travel and Doctors Clinics Inc., Announces Share Subscription Agreement with GEM Global Yield LLC SCS, and Provides Update on Delay in Filing Financial Statements
Not for dissemination in the United States of America VANCOUVER, British Columbia, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Aja Health...
Press Release: Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia
Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia Novel treatment targets BTK through multi-immune modulation to...
Biomerica Reports Fiscal 2025 Year End Results
$1.3 Million in Operating Expense Reductions Achieved– Operating Loss Improves 19% Year-Over-YearResilient Portfolio Performance with International Sales Despite Global Economic...
FDA Approves LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
LEQEMBI IQLIK is the first and only anti-amyloid treatment to offer an at-home injection to help patients and care partners...
Alliance Recovery Expands in Orange County, California, Improving Access to Affordable Addiction Treatment
Expansion at Alliance Recovery in Orange County, CA increases treatment capacity by 16 and paves the way for a future...
Integra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor Conferences
PRINCETON, N.J., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company,...